What does Kadmon holdings do?

About Us. Kadmon, a Sanofi Company, is a biopharmaceutical company that discovers, develops and markets transformative therapies for unmet medical needs. Our clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.

Who owns Kadmon?

Sanofi
Kadmon Corporation
Kadmon Corporation/Parent organizations

Where is Kadmon located?

New York City
Kadmon Corporation (originally Kadmon Pharmaceuticals) is a biopharmaceutical company based in New York City. It also has operations in Warrendale, PA and Brighton, MA. The company was founded in 2009 by Samuel D.

How many employees does Kadmon have?

127 total
Company Description: Kadmon Holdings, Inc. is located in New York, NY, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Kadmon Holdings, Inc. has 127 total employees across all of its locations and generates $8.29 million in sales (USD).

What company did Sanofi buy?

Kadmon
Sanofi to acquire Kadmon to further strengthen growth of transplant business. PARIS and NEW YORK – September 8, 2021 – Sanofi has entered into a definitive merger agreement with Kadmon Holdings, Inc.

Who bought KDMN?

Sanofi (SNY) said Wednesday it will spend $1.9 billion to acquire small biotech Kadmon Holdings (KDMN), and KDMN stock rocketed to a five-year high. The deal adds Kadmon’s transplant drug Rezurock to Sanofi’s general medicines business.

Why did Sanofi buy Kadmon?

Paris – November 9, 2021 – Sanofi announced today the completion of its acquisition of Kadmon Holdings, Inc. The acquisition further strengthens growth and expansion for the General Medicines portfolio.

Does Sanofi have a Covid vaccine?

On February 23rd 2022, we announced that we intend to submit data from both our booster and Phase 3 efficacy trials as the basis for regulatory applications for a COVID-19 vaccine.

Is Sanofi sold?

Drug firm Sanofi India said its board has approved selling its nutraceuticals business to Universal Nutriscience for ₹587 crore.

Should I sell Kadmon stock?

The consensus among Wall Street equities research analysts is that investors should “hold” Kadmon stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KDMN, but not buy additional shares or sell existing shares.

Is Sanofi a French company?

Sanofi-Aventis, French pharmaceutical company founded in 2004 through the merger of Sanofi-Synthélabo SA and a much larger French firm, Aventis. Primarily focused on the development and sale of prescription medications, Sanofi-Aventis is one of Europe’s largest pharmaceutical firms.

Is the Sanofi vaccine mRNA?

Our first mRNA-based Vaccine Candidate – Sanofi.